Discovery of Cyclic Peptide Ligands to the SARS-CoV-2 Spike Protein using mRNA Display
Preprint
- 23 December 2020
- preprint
- research article
- Published by Cold Spring Harbor Laboratory
Abstract
The COVID-19 pandemic, caused by SARS-CoV-2, has led to substantial morbidity, mortality and disruption globally. Cellular entry of SARS-CoV-2 is mediated by the viral spike protein and affinity ligands to this surface protein have the potential for applications as antivirals and diagnostic reagents. Here, we describe the affinity selection of cyclic peptide ligands to the SARS-CoV-2 spike protein receptor binding domain (RBD) from three distinct libraries (in excess of a trillion molecules each) by mRNA display. We identified six high affinity molecules with dissociation constants (KD) in the nanomolar range (15-550 nM) to the RBD. The highest affinity ligand could be used as an affinity reagent to detect spike protein in solution by ELISA, and the co-crystal structure of this molecule bound to the RBD demonstrated that it binds to a cryptic binding site, displacing a β-strand near the C-terminus. Our findings provide key mechanistic insight into the binding of peptide ligands to the SARS-CoV-2 spike RBD and the ligands discovered in this work may find future use as reagents for diagnostic applications.Keywords
Other Versions
- Published version: Version ACS Central Science, 7, preprints
This publication has 56 references indexed in Scilit:
- De novo macrocyclic peptides that specifically modulate Lys48-linked ubiquitin chainsNature Chemistry, 2019
- Macrocyclic peptide-based inhibition and imaging of hepatocyte growth factorNature Chemical Biology, 2019
- Targeting intracellular protein–protein interactions with cell-permeable cyclic peptidesCurrent Opinion in Chemical Biology, 2017
- Targeting protein−protein interfaces using macrocyclic peptidesPeptide Science, 2015
- Macrocycles: lessons from the distant past, recent developments, and future directionsChemical Science, 2014
- Tools and rules for macrocyclesNature Chemical Biology, 2014
- A Cyclic Peptide Inhibitor of HIF-1 Heterodimerization That Inhibits Hypoxia Signaling in Cancer CellsJournal of the American Chemical Society, 2013
- Bicyclic Peptide Inhibitor Reveals Large Contact Interface with a Protease TargetACS Chemical Biology, 2012
- Natural Product-Like Macrocyclic N-Methyl-Peptide Inhibitors against a Ubiquitin Ligase Uncovered from a Ribosome-Expressed De Novo LibraryCell Chemical Biology, 2011
- The exploration of macrocycles for drug discovery — an underexploited structural classNature Reviews Drug Discovery, 2008